Medical Bionic Implant/Artificial Organs Market Research Report – Forecast to 2027

Medical Bionic Implant/Artificial Organs Market Research Report: By Technology (Mechanical, Electronic Bionics), Product (Vision, Ear, Orthopedic, Heart, Neural/Brain), Fixation (Implantable, Externally Worn), End-User -Forecast Till 2027

ID: MRFR/MED/4593-HCR | February 2021 | Region: Global | 100 pages

Medical Bionic Implant/Artificial Organs Market Scenario


The medical bionic implant/artificial organs market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the medical bionic implant/artificial organs market is expected to register a CAGR of 7.0% during the forecast period of 2018–2023.


Bionic implants are artificially engineered devices that are implanted into a human to replace a natural organ. The main purpose of bionic implants is to provide life support to prevent imminent death while awaiting a transplant and improve a patient's ability to interact socially.


It is observed that the increasing cases of organ failure have increased the demand for replaceable organs, which is propelling the medical bionic implant/artificial organs market to a great extent. According to the statistics suggested by the National Kidney Foundation, 2016  around 121,678 people were waiting for lifesaving organ transplants in the in the United States. It is also reported that in 2014, 17,107 kidney transplants took place in the U.S. The incidences of organ failure are found to be more common in the aging population, as it is more vulnerable towards health issues such as ophthalmic diseases, gastrointestinal problems, orthopedic diseases, cancer, and others.


Various other factors such as technological advancements, increasing accidents and injuries, improving regulatory framework, increasing government assistance, and increasing prevalence of eye diseases are continuously contributing to the growth of the global medical bionic implant/artificial organs market.


Despite these drivers, there are some issues associated with the medical bionic implant/artificial organs market. Lack of skilled professionals, the high cost of devices, fear of malfunction of devices, and poor healthcare system in low and middle-income countries may hamper the growth of the medical bionic implant/artificial organs market to an extent.


Regional Market Summary


The Americas dominates the medical bionic implant/artificial organs market owing to the introduction of advanced medical bionic implants by major market players. On November 02, 2017, Second Sight Medical Products, Inc., a U.S. based company, received the U.S. FDA approval to initiate the Orion Cortical Visual Prosthesis System (Orion) feasibility clinical study. In 2013, the company won the FDA approval for the Argus II retinal prosthesis system.


Europe holds the second position in the medical bionic implant/artificial organs market. It is expected that the government support towards research and development expenditure and increasing cases of organ failure and related complications are likely to drive the European market.


Asia Pacific is the fastest growing medical bionic implant/artificial organs market owing to a huge patient pool, increasing demand for advanced treatments, and development in the healthcare technology. Healthcare expenditure is found to be improving in various Asia Pacific regions. According to the data suggested by Australian Institute of Health and Welfare during the year 2015 to 2016, the total health expenditure was USD 170.4 billion, i.e., 3.6% higher than the expenditure during 2014 to 2015.


The Middle East and Africa holds the lowest share of the global medical bionic implant/artificial organs market due to low development, lack of technical knowledge, and poor medical facilities.


Key Players


Some of key the players in the global medical bionic implant/artificial organs  market are Aleva Neurotherapeutics SA (Switzerland), Biocontrol Medical (Israel), Biomet, Inc. (U.S.), Boston Scientific Corporation (U.S.), Cochlear Ltd. (Australia), Cyberonics, Inc. (U.S.), Ekso Bionics (U.S.), LivaNova PLC (U.K), Medtronic, Inc. (U.S.), NeuroPace, Inc. (U.S.), Orthofix International N.V. (The Netherlands), Ossur (Iceland), Second Sight Medical Products, Inc. (U.S.), and St. Jude Medical, Inc. (U.S.).


Research Methodology


Market Research Future research is conducted by industry experts who offer insight into industry structure, market segmentation, treatment assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analyzing historical trends and current market positions. Furthermore, varying trends of segments and categories geographically presented are studied and are estimated based on the primary and secondary research.



  • Primary Research


The extensive primary research was conducted to gain a deeper insight of the market and the industry performance. In this particular report, we have conducted primary surveys (interviews) with key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.



  • Secondary Research


Secondary research was mainly used to collect and identify information useful for an extensive, technical, market-oriented, and commercial study of the medical bionic implant market. It was also used to obtain key information about major players, market classification and segmentation according to industry trends, geographical markets and developments related to the market, and treatment perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company websites, the international organization of chemical manufacturers, some paid databases, and many others.


Segmentation


The medical bionic implant/artificial organs market is segmented by technology, product, fixation, and end-user.


By technology, the medical bionic implant/artificial organs market is classified as mechanical bionics and electronic bionics.


By product, the medical bionic implant/artificial organs market is classified as vision bionics, ear bionics, orthopedic bionics, heart bionics, neural/brain bionics, and others. Vision bionics are further segmented as bionic eye and others. Ear bionics are further segmented as cochlear implant, and Bone Anchored Hearing Aid (BAHA). Orthopedic bionics are further segmented as bionic hand, bionic leg, bionic finger, exoskeleton, and electrical bone growth stimulators. The sub-segments of bionic leg include bionic knee and bionic feet. The sub-segments of electrical bone growth stimulators include invasive bone growth stimulators and non-invasive bone growth stimulators. Heart bionics are further segmented as pacemaker, total artificial heart, ventricular assist device, and artificial heart valve. The sub-segments of pacemaker include implantable cardiac pacemaker and external pacemaker. The sub-segments of artificial heart valve include mechanical heart valve and tissue heart valve. Neural/brain bionics are further segmented as deep brain stimulators, vagus nerve stimulators, and spinal cord stimulators.


By fixation, the medical bionic implant/artificial organs market is segmented into implantable and externally worn.


By end-user, the medical bionic implant/artificial organs market is segmented into hospitals and clinics, research and academic institutes, and others.


Intended Audience



  • Medical Device Companies

  • Research and Development (R&D) Companies

  • Diagnostic Laboratories

  • Government Research Institutes

  • Academic Institutes and Universities



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   7.0% (2018-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Technology, Product, Fixation, and End-user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Aleva Neurotherapeutics SA (Switzerland), Biocontrol Medical (Israel), Biomet, Inc. (U.S.), Boston Scientific Corporation (U.S.), Cochlear Ltd. (Australia), Cyberonics, Inc. (U.S.), Ekso Bionics (U.S.), LivaNova PLC (U.K), Medtronic, Inc. (U.S.), NeuroPace, Inc. (U.S.), Orthofix International N.V. (The Netherlands), Ossur (Iceland), Second Sight Medical Products, Inc. (U.S.), and St. Jude Medical, Inc. (U.S.).
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Technological advancements
  • Increasing accidents and injuries
  • Improving regulatory framework
  • Increasing government assistance Increasing prevalence of eye diseases


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    Medical Bionic Implant/Artificial Organs Market is projected to grow at a 7.0% CAGR between 2018-2023.

    The Americas is expected to lead the Medical Bionic Implant/Artificial Organs Market.

    Improving regulatory framework and increasing injuries and accidents are adding market growth.

    High cost and poor healthcare system may limit market growth.

    Different strategies used by market players to create a dominance in the Medical Bionic Implant/Artificial Organs Market include mergers and acquisitions, collaborations, product launches, and strategic alliances.

    Table Of Contents:

    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope Of The Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power Of Suppliers

    5.1.2 Bargaining Power Of Buyers

    5.1.3 Threat Of New Entrants

    5.1.4 Threat Of Substitutes

    5.1.5 Intensity Of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    Chapter 6. Global Medical Bionic Implant/Artificial Organs Market, By Technology

    6.1 Introduction

    6.2 Mechanical Bionics

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    6.3 Electronic Bionics

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    6.4 Others

    Chapter 7. Global Medical Bionic Implant/Artificial Organs Market, By Product

    7.1 Introduction

    7.2 Vision Bionics

    7.2.1 Bionic Eye

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.2.2 Others

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.3 Ear Bionics

    7.3.1 Cochlear Implant

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.3.2 Bone Anchored Hearing Aid (BAHA)

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.4 Orthopedic Bionics

    7.4.1 Bionic Hand

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.4.2 Bionic Leg

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.4.2.1 Bionic Knee

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.4.2.2 Bionic Feet

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.4.3 Bionic Finger

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.4.4 Exoskeleton

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.4.5 Electrical Bone Growth Stimulators

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.4.5.1 Invasive Bone Growth Stimulators

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.4.5.2 Non-Invasive Bone Growth Stimulators

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By +9+, 2020–2027

    7.4.6 Heart Bionics

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.4.6.1 Pacemaker

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.4.6.1.1 Implantable Cardiac Pacemaker

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.4.6.1.2 External Pacemaker

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.4.6.2 Total Artificial Heart

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.4.6.3 Ventricular Assist Device

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.4.6.4 Artificial Heart Valve

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.4.6.4.1 Mechanical Heart Valve

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.4.6.4.2 Tissue Heart Valve

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.4.7 Neural/Brain Bionics

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.4.7.1 Deep Brain Stimulator

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.4.7.2 Vagus Nerve Stimulator

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.4.7.3 Spinal Cord Stimulator

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    Chapter 8. Global Medical Bionic Implant/Artificial Organs Market, By Fixation

    8.1 Introduction

    8.2 Implantable

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    8.3 Externally Worn

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    Chapter 9. Global Medical Bionic Implant/Artificial Organs Market, By End-User

    9.1 Introduction

    9.2 Hospitals & Clinics

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    9.3 Research And Academic Institutes

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    9.4 Others

    Chapter 10. Global Medical Bionic Implant/Artificial Organs Market, By Region

    10.1 Introduction

    10.2 Americas

    10.2.1 North America

    10.2.1.1 U.S.

    10.2.1.2 Canada

    10.2.2 South America

    10.3 Europe

    10.3.1 Western Europe

    10.3.1.1 Germany

    10.3.1.2 France

    10.3.1.3 Italy

    10.3.1.4 Spain

    10.3.1.5 U.K.

    10.3.1.6 Rest Of Western Europe

    10.3.2 Eastern Europe

    10.4 Asia Pacific

    10.4.1 Japan

    10.4.2 China

    10.4.3 India

    10.4.4 Australia

    10.4.5 Republic Of Korea

    10.4.6 Rest Of Asia Pacific

    10.5 The Middle East & Africa

    10.5.1 The Middle East

    10.5.2 Africa

    Chapter 11. Company Landscape

    11.1 Introduction

    11.2 Market Share Analysis

    11.3 Key Development & Strategies

    Chapter 12. Company Profiles

    12.1 Aleva Neurotherapeutics SA

    12.1.1 Company Overview

    12.1.2 Product Overview

    12.1.3 Financials

    12.1.4 SWOT Analysis

    12.2 Biocontrol Medical

    12.2.1 Company Overview

    12.2.2 Product Overview

    12.2.3 Financial Overview

    12.2.4 Key Developments

    12.2.5 SWOT Analysis

    12.3 Biomet, Inc.

    12.3.1 Company Overview

    12.3.2 Product Overview

    12.3.3 Financial Overview

    12.3.4 Key Development

    12.3.5 SWOT Analysis

    12.4 Boston Scientific Corporation

    12.4.1 Company Overview

    12.4.2 Technology/Business Segment Overview

    12.4.3 Financial Overview

    12.4.4 Key Development

    12.4.5 SWOT Analysis

    12.5 Cochlear Ltd.

    12.5.1 Company Overview

    12.5.2 Product Overview

    12.5.3 Financial Overview

    12.5.4 Key Developments

    12.6 Cyberonics, Inc.

    12.6.1 Company Overview

    12.6.2 Product Overview

    12.6.3 Financial Overview

    12.6.4 Key Developments

    12.7 Ekso Bionics

    12.7.1 Overview

    12.7.2 Product Overview

    12.7.3 Financials

    12.7.4 Key Developments

    12.7.5 SWOT Analysis

    12.8 LivaNova PLC

    12.8.1 Overview

    12.8.2 Medical Bionic Implant/Artificial Organs Overview

    12.8.3 Financials

    12.8.4 Key Developments

    12.8.5 SWOT Analysis

    12.9 Medtronic, Inc.

    12.9.1 Overview

    12.9.2 Medical Bionic Implant/Artificial Organs Overview

    12.9.3 Financials

    12.9.4 Key Developments

    12.9.5 SWOT Analysis

    12.10 NeuroPace, Inc.

    12.10.1 Overview

    12.10.2 Medical Bionic Implant/Artificial Organs Overview

    12.10.3 Financials

    12.10.4 Key Developments

    12.10.5 SWOT Analysis

    12.11 Orthofix International N.V.

    12.11.1 Overview

    12.11.2 Medical Bionic Implant/Artificial Organs Overview

    12.11.3 Financials

    12.11.4 Key Developments

    12.11.5 SWOT Analysis

    12.12 Ossur

    12.12.1 Overview

    12.12.2 Medical Bionic Implant/Artificial Organs Overview

    12.12.3 Financials

    12.12.4 Key Developments

    12.12.5 SWOT Analysis

    12.12 Second Sight Medical Products, Inc.

    12.12.1 Overview

    12.12.2 Medical Bionic Implant/Artificial Organs Overview

    12.12.3 Financials

    12.12.4 Key Developments

    12.12.5 SWOT Analysis

    12.14 St. Jude Medical, Inc.

    12.14.1 Overview

    12.14.2 Medical Bionic Implant/Artificial Organs Overview

    12.14.3 Financials

    12.14.4 Key Developments

    12.14.5 SWOT Analysis

    12.12 Others

    Chapter 13 MRFR Conclusion

    13.1 Key Findings

    13.1.1 From CEO’s View Point

    13.1.2 Unmet Needs Of The Market

    13.2 Key Companies To Watch

    13.3 Prediction Of The Medical Bionic Implant/Artificial Organs Industry

    Chapter 14 Appendix

    LIST OF TABLES

    Table 1 Medical Bionic Implant/Artificial Organs Industry Synopsis, 2020–2027

    Table 2 Medical Bionic Implant/Artificial Organs Market Estimates And Forecast, 2020–2027, (USD Million)

    Table 3 Medical Bionic Implant/Artificial Organs Market, By Region, 2020–2027, (USD Million)

    Table 4 Medical Bionic Implant/Artificial Organs Market, By Technology, 2020–2027, (USD Million)

    Table 5 Medical Bionic Implant/Artificial Organs Market, By Product, 2020–2027, (USD Million)

    Table 6 Medical Bionic Implant/Artificial Organs Market, By Fixation, 2020–2027, (USD Million)

    Table 7 Medical Bionic Implant/Artificial Organs Market, By End-User, 2020–2027, (USD Million)

    Table 8 North America Medical Bionic Implant/Artificial Organs Market, By Technology, 2020–2027, (USD Million)

    Table 9 North America Medical Bionic Implant/Artificial Organs Market, By Product, 2020–2027, (USD Million)

    Table 10 North America Medical Bionic Implant/Artificial Organs Market, By Fixation, 2020–2027, (USD Million)

    Table 11 North America Medical Bionic Implant/Artificial Organs Market, By End-User, 2020–2027, (USD Million)

    Table 12 U.S. Medical Bionic Implant/Artificial Organs Market, By Technology, 2020–2027, (USD Million)

    Table 13 U.S. Medical Bionic Implant/Artificial Organs Market, By Product, 2020–2027, (USD Million)

    Table 13 U.S. Medical Bionic Implant/Artificial Organs Market, By Fixation, 2020–2027, (USD Million)

    Table 15 U.S. Medical Bionic Implant/Artificial Organs Market, By End-User, 2020–2027, (USD Million)

    Table 16 Canada Medical Bionic Implant/Artificial Organs Market, By Technology, 2020–2027, (USD Million)

    Table 17 Canada Medical Bionic Implant/Artificial Organs Market, By Product, 2020–2027, (USD Million)

    Table 18 Canada Medical Bionic Implant/Artificial Organs Market, By Fixation, 2020–2027, (USD Million)

    Table 19 Canada Medical Bionic Implant/Artificial Organs Market, By End-User, 2020–2027, (USD Million)

    Table 20 South America Medical Bionic Implant/Artificial Organs Market, By Technology, 2020–2027, (USD Million)

    Table 21 South America Medical Bionic Implant/Artificial Organs Market, By Product, 2020–2027, (USD Million

    Table 22 South America Medical Bionic Implant/Artificial Organs Market, By Fixation, 2020–2027, (USD Million

    Table 23 South America Medical Bionic Implant/Artificial Organs Market, By End-User, 2020–2027, (USD Million)

    Table 24 Europe Medical Bionic Implant/Artificial Organs Market, By Technology, 2020–2027, (USD Million)

    Table 25 Europe Medical Bionic Implant/Artificial Organs Market, By Product, 2020–2027, (USD Million)

    Table 26 Europe Medical Bionic Implant/Artificial Organs Market, By Fixation, 2020–2027, (USD Million)

    Table 27 Europe Medical Bionic Implant/Artificial Organs Market, By End-User, 2020–2027, (USD Million)

    Table 28 Western Europe Medical Bionic Implant/Artificial Organs Market, By Technology, 2020–2027, (USD Million)

    Table 29 Western Europe Medical Bionic Implant/Artificial Organs Market, By Product, 2020–2027, (USD Million)

    Table 30 Western Europe Medical Bionic Implant/Artificial Organs Market, By Fixation, 2020–2027, (USD Million)

    Table 31 Western Europe Medical Bionic Implant/Artificial Organs Market, By End-User, 2020–2027, (USD Million)

    Table 32 Eastern Europe Medical Bionic Implant/Artificial Organs Market, By Technology, 2020–2027, (USD Million)

    Table 33 Eastern Europe Medical Bionic Implant/Artificial Organs Market, By Product, 2020–2027, (USD Million)

    Table 34 Eastern Europe Medical Bionic Implant/Artificial Organs Market, By Fixation, 2020–2027, (USD Million)

    Table 35 Eastern Europe Medical Bionic Implant/Artificial Organs Market, By End-User, 2020–2027, (USD Million)

    Table 36 Asia Pacific Medical Bionic Implant/Artificial Organs Market, By Technology, 2020–2027, (USD Million)

    Table 37 Asia Pacific Medical Bionic Implant/Artificial Organs Market, By Product, 2020–2027, (USD Million)

    Table 38 Asia Pacific Medical Bionic Implant/Artificial Organs Market, By Fixation, 2020–2027, (USD Million)

    Table 39 Asia Pacific Medical Bionic Implant/Artificial Organs Market, By End-User, 2020–2027, (USD Million)

    Table 40 Middle East & Africa Medical Bionic Implant/Artificial Organs Market, By Technology, 2020–2027, (USD Million)

    Table 41 Middle East & Africa Medical Bionic Implant/Artificial Organs Market, By Product, 2020–2027, (USD Million)

    Table 42 Middle East & Africa Medical Bionic Implant/Artificial Organs Market, By Fixation, 2020–2027, (USD Million)

    Table 43 Middle East & Africa Medical Bionic Implant/Artificial Organs Market, By End-User, 2020–2027, (USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation For Medical Bionic Implant/Artificial Organs Market

    Figure 3 Segmentation Market Dynamics For Medical Bionic Implant/Artificial Organs Market

    Figure 4 Global Medical Bionic Implant/Artificial Organs Market Share, By Technology 2020

    Figure 5 Global Medical Bionic Implant/Artificial Organs Market Share, By Product 2020

    Figure 6 Global Medical Bionic Implant/Artificial Organs Market Share, By Fixation 2020

    Figure 7 Global Medical Bionic Implant/Artificial Organs Market Share, By End-User, 2020

    Figure 8 Global Medical Bionic Implant/Artificial Organs Market Share, By Region, 2020

    Figure 9 North America Medical Bionic Implant/Artificial Organs Market Share, By Country, 2020

    Figure 10 Europe Medical Bionic Implant/Artificial Organs Market Share, By Country, 2020

    Figure 11 Asia Pacific Medical Bionic Implant/Artificial Organs Market Share, By Country, 2020

    Figure 12 Middle East & Africa Medical Bionic Implant/Artificial Organs Market Share, By Country, 2020

    Figure 13 Global Medical Bionic Implant/Artificial Organs Market: Company Share Analysis, 2020 (%)

    Figure 13 Aleva Neurotherapeutics SA: Key Financials

    Figure 15 Aleva Neurotherapeutics SA Segmental Revenue

    Figure 16 Aleva Neurotherapeutics SA: Geographical Revenue

    Figure 17 Biocontrol Medical: Key Financials

    Figure 18 Biocontrol Medical: Segmental Revenue

    Figure 19 Biocontrol Medical: Geographical Revenue

    Figure 20 Biomet, Inc.: Key Financials

    Figure 21 Biomet, Inc.: Segmental Revenue

    Figure 22 Biomet, Inc.: Geographical Revenue

    Figure 23 Boston Scientific Corporation: Key Financials

    Figure 24 Boston Scientific Corporation: Segmental Revenue

    Figure 25 Boston Scientific Corporation: Geographical Revenue

    Figure 26 Cochlear Ltd.: Key Financials

    Figure 27 Cochlear Ltd.: Segmental Revenue

    Figure 28 Cochlear Ltd. Geographical Revenue

    Figure 29 Cyberonics, Inc.: Key Financials

    Figure 30 Cyberonics, Inc.: Segmental Revenue

    Figure 31 Cyberonics, Inc.: Geographical Revenue

    Figure 32 Ekso Bionics Inc.: Key Financials

    Figure 33 Ekso Bionics Inc.: Segmental Revenue

    Figure 34 Ekso Bionics Inc.: Geographical Revenue

    Figure 35 LivaNova PLC: Key Financials

    Figure 36 LivaNova PLC: Segmental Revenue

    Figure 37 LivaNova PLC: Geographical Revenue

    Figure 38 Medtronic, Inc.: Key Financials

    Figure 39 Medtronic, Inc.: Segmental Revenue

    Figure 40 Medtronic, Inc.: Geographical Revenue

    Figure 41 NeuroPace, Inc.: Key Financials

    Figure 42 NeuroPace, Inc.: Segmental Revenue

    Figure 43 NeuroPace, Inc.: Geographical Revenue

    Figure 44 Orthofix International N.V.: Key Financials

    Figure 45 Orthofix International N.V.: Segmental Revenue

    Figure 46 Orthofix International N.V.: Geographical Revenue